BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38727478)

  • 1. Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.
    Krönert MIC; Schwarzenböck SM; Kurth J; Heuschkel M; Krause BJ; Emmert S; Tietze JK
    Healthcare (Basel); 2024 Apr; 12(9):. PubMed ID: 38727478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose brachytherapy with non sealed
    Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1511-1521. PubMed ID: 33140131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 188Re Ionizing Radiation Therapy Exerts High Efficacy in Curing Nonmelanoma Skin Cancer.
    Tietze JK; Heuschkel M; Krönert MIC; Kurth J; Bandow G; Ojak G; Grünwald P; Herold JI; Thiem A; Dreßler M; Krause BJ; Emmert S; Schwarzenböck SM
    Clin Nucl Med; 2023 Oct; 48(10):869-876. PubMed ID: 37682602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study.
    Cipriani C; Desantis M; Dahlhoff G; Brown SD; Wendler T; Olmeda M; Pietsch G; Eberlein B
    J Dermatolog Treat; 2022 Mar; 33(2):969-975. PubMed ID: 32648530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional myocardial strain measurements from 4DCT in patients with normal LV function.
    McVeigh ER; Pourmorteza A; Guttman M; Sandfort V; Contijoch F; Budhiraja S; Chen Z; Bluemke DA; Chen MY
    J Cardiovasc Comput Tomogr; 2018; 12(5):372-378. PubMed ID: 29784623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Regional Shortening from 4D Cardiac CT Angiography for the Detection of Left Ventricular Segmental Wall Motion Abnormality.
    Chen Z; Contijoch F; Kahn AM; Kligerman S; Narayan HK; Manohar A; McVeigh E
    Radiol Cardiothorac Imaging; 2023 Apr; 5(2):e220134. PubMed ID: 37124646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior modification and risk perception in patients with nonmelanoma skin cancer.
    Rhee JS; Davis-Malesevich M; Logan BR; Neuburg M; Burzynski M; Nattinger AB
    WMJ; 2008 Apr; 107(2):62-8. PubMed ID: 18593080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrochemotherapy with intravenous bleomycin for advanced non-melanoma skin cancers and for cutaneous and subcutaneous metastases from melanoma.
    Tomassini GM; Covarelli P; Tomassini MA; Corsi A; Bianchi L; Hansel K; Stingeni L
    G Ital Dermatol Venereol; 2016 Oct; 151(5):499-506. PubMed ID: 27595201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
    Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
    J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer.
    Boeri M; Skelsey MK; Schiro JA; Dozier SE; Glinert R; Okun MM
    J Dermatolog Treat; 2023 Dec; 34(1):2247105. PubMed ID: 37587862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel tool for predicting the dose distribution of non-sealed
    Zagni F; Vichi S; Paolani G; Santoro M; Della Gala G; Strolin S; Castellucci P; Vetrone L; Fanti S; Morganti AG; Strigari L
    Med Phys; 2023 Jul; 50(7):4600-4612. PubMed ID: 36919341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats.
    Sinko PJ; Smith CL; McWhorter LT; Stern W; Wagner E; Gilligan JP
    J Pharm Sci; 1995 Nov; 84(11):1374-8. PubMed ID: 8587058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical indications for the management of non-melanoma skin cancer patients.
    DI Stefani A; Del Regno L; Piccerillo A; Peris K
    G Ital Dermatol Venereol; 2017 Jun; 152(3):286-294. PubMed ID: 28195452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality treatment for non melanoma skin cancer: a prospective study done on 120 egyptian patients.
    Mebed AH; Soliman HO; Gad ZS; Abdel Hay RM
    J Egypt Natl Canc Inst; 2010 Mar; 22(1):49-55. PubMed ID: 21503006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
    Sidoroff A; Thaler P
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of using ultrasound during follow-up for superficial non-melanoma skin cancers after electronic brachytherapy.
    Goyal U; Suszko J; Stea B
    J Contemp Brachytherapy; 2017 Dec; 9(6):535-539. PubMed ID: 29441097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement in a Personal Injury Claim Is Associated With More Pain and Delayed Return to Work After Elective Nonsurgical or Surgical Treatment for Hand or Wrist Disorders: A Propensity Score-matched Comparative Study.
    Hoogendam L; van der Oest MJW; Souer JS; Selles RW; Hovius SER; Feitz R;
    Clin Orthop Relat Res; 2023 Apr; 481(4):751-762. PubMed ID: 36155596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
    Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.